Last reviewed · How we verify
Dexmedetomidine 02
At a glance
| Generic name | Dexmedetomidine 02 |
|---|---|
| Sponsor | Guangzhou General Hospital of Guangzhou Military Command |
| Modality | Small molecule |
| Phase | FDA-approved |
Approved indications
Common side effects
Key clinical trials
- Intravenous Dexmeditomidine for Prevention of Spinal Anesthesia Induced Shivering. (PHASE4)
- Postpartum Women's Dexmedetomidine Sedation (PHASE4)
- The Influence of Age on Dexmedetomidine Pharmacodynamic (PHASE4)
- Comparative Study of Nonintubated Anesthesia Versus Intubated General Anesthesia in Single Port Thoracoscopic Bullectomy (NA)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Dexmedetomidine 02 CI brief — competitive landscape report
- Dexmedetomidine 02 updates RSS · CI watch RSS
- Guangzhou General Hospital of Guangzhou Military Command portfolio CI